Cytokinetics, Inc. - CYTK - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 26, 2013

Cytokinetics, Inc. - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
CYTK	Nasdaq	8731	http://www.cytokinetics.com/	1.16 -0.02
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Cytokinetics, Inc. CYTOKINETICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - May 24th, 2013 7:44 am Cytokinetics' CEO Hosts the Annual Meeting of Stockholders Conference (Transcript) - May 22nd, 2013 10:16 pm Cytokinetics to Hold Annual Meeting of Stockholders - May 15th, 2013 2:02 pm CYTOKINETICS INC Financials - May 14th, 2013 11:04 am SmithOnStocks Opines On Recent Biotech News - May 13th, 2013 3:38 am CYTOKINETICS INC Files SEC form 10-Q, Quarterly Report - May 8th, 2013 5:15 am Cytokinetics, Incorporated Reports First Quarter 2013 Financial Results - Apr 30th, 2013 6:00 pm Cytokinetics' CEO Discusses Q1 2013 Results - Earnings Call Transcript - Apr 30th, 2013 4:43 pm Cytokinetics, Inc. Earnings Call scheduled for 4:30 pm ET today - Apr 30th, 2013 2:30 pm Cytokinetics, Incorporated Reports First Quarter 2013 Financial Results - Apr 30th, 2013 2:02 pm CYTOKINETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - Apr 30th, 2013 7:09 am A New Approach to Treating a Broken Heart - Apr 30th, 2013 5:08 am Q1 2013 Cytokinetics, Inc. Earnings Release - 4:00 pm ET - Apr 30th, 2013 5:07 am The Fool Looks Ahead - Apr 27th, 2013 5:15 am 5 Stocks Poised for Breakouts - Apr 19th, 2013 12:13 pm 2 High Risk Biotech Stocks Under $2 That Could Yield A High Reward - Apr 17th, 2013 8:48 am Cytokinetics to Announce First Quarter Results on April 30, 2013 - Apr 16th, 2013 4:15 pm Cytokinetics to Announce First Quarter Results on April 30, 2013 - Apr 16th, 2013 2:02 pm Cytokinetics: Key Issues For Beginning Phase III For Omecamtiv Mecarbil In Congestive Heart Failure - Apr 11th, 2013 11:14 am Patients Dosed in Arena Study - Apr 9th, 2013 3:25 pm View All Current Headlines >>